- Associated Press•2 years ago
Shares of Salix Pharmaceuticals fell Wednesday before markets opened and a day after it announced plans to become the latest U.S. company to incorporate overseas and lower its taxes. The Raleigh, North ...
- GuruFocus.com•3 years ago
Mario Gabelli (Trades, Portfolio)’s GAMCO Investors is in top form. The firm on Feb. 4 reported record assets under management at $47.0 billion, with a 93% increase in earnings per share and 24% increase ...
- Zacks•3 years ago
Threshold Pharma completed enrolling patients in its phase III study, which is being conducted to evaluate TH-302 for the treatment of advanced soft tissue sarcoma.
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|